Financhill
Back

Relay Therapeutics Quote, Financials, Valuation and Earnings

Relay Therapeutics Price Quote

$4.17
+0.00 (+-2.11%)
(Updated: December 21, 2024 at 5:44 AM ET)

Relay Therapeutics Key Stats

Sell
15
Relay Therapeutics (RLAY) is a Sell

Day range:
$4.15 - $4.32
52-week range:
$4.11 - $12.14
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
15.58
P/B ratio:
0.83%

Volume:
6.3M
Avg. volume:
2.4M
1-year change:
-60.37%
Market cap:
$697.2M
Revenue:
$25.5M
EPS:
$-2.61

How Much Does Relay Therapeutics Make?

Data Unavailable

Is Relay Therapeutics Growing As A Company?

Data Unavailable

Relay Therapeutics Stock Price Performance

What Is Relay Therapeutics 52-Week High & Low?

Relay Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Relay Therapeutics?

Data Unavailable

Is Relay Therapeutics Cash Flow Positive?

Data Unavailable

Relay Therapeutics Return On Invested Capital

Data Unavailable

Relay Therapeutics Earnings Date & Stock Price

Relay Therapeutics Competitors

  • Who Are Relay Therapeutics's Competitors?
    Below is a list of companies who compete with Relay Therapeutics or are related in some way:
    • Arbutus Biopharma Corp (ABUS)
    • Biomarin Pharmaceutical Inc (BMRN)
    • GlycoMimetics Inc (GLYC)
    • Lexicon Pharmaceuticals Inc (LXRX)
    • Precigen Inc (PGEN)

Relay Therapeutics Dividend Yield

Data Unavailable

Relay Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 19.62%
Revenue: 4327.88% -100%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable